References: Hair growth and hair loss
Arch Dermatol. 2001 Aug;137(8):1063-8.
Predictive model for immunotherapy of alopecia areata with diphencyprone.
Wiseman MC, Shapiro J, MacDonald N, Lui H.
Division of Dermatology, Vancouver General Hospital, University of British Columbia, 835 W 10th Ave, Vancouver, British Columbia, Canada V5Z 4E8.
BACKGROUND: Immunotherapy with diphencyprone (diphenylcyclopropenone) is used in the treatment of alopecia areata (AA). Response rates have varied in the literature. OBJECTIVES: To determine the efficacy of diphencyprone therapy for AA in the largest reported cohort of patients; to identify patient and treatment factors predictive of therapeutic success; and to develop a practical model for predicting patient response. METHODS: The medical records of 148 consecutive patients treated with diphencyprone were reviewed. A clinically significant response to diphencyprone therapy was defined as a cosmetically acceptable response or greater than 75% terminal hair regrowth. Survival analyses using the Kaplan-Meier method and the Cox proportional hazards model were performed to determine significant factors predictive of regrowth and relapse. RESULTS: Using a survival analysis model, the cumulative patient response at 32 months was 77.9% (95% confidence interval, 56.8%-98.9%). Variables independently associated with clinically significant regrowth were age at onset of disease and baseline extent of AA. Older age at onset of AA portended a better prognosis. A cosmetically acceptable end point was obtained in 17.4% of patients with alopecia totalis/universalis, 60.3% with 75% to 99% AA, 88.1% with 50% to 74% AA, and 100% with 25% to 49% AA. A lag of 3 months was present between initiation of therapy and development of significant hair regrowth in the first responders. Relapse after achieving significant regrowth developed in 62.6% of patients. CONCLUSIONS: Response to diphencyprone treatment in AA is affected by baseline extent of AA and age at disease onset. A prolonged treatment course might be necessary. A predictive model has been developed to assist with patient prognostication and counseling.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11493099&dopt=Abstract
mailer.uni-marburg.de
Alopecia areata-like hair loss has been observed in C3H/HeJ mice and can be defined as a tissue-restricted T cell mediated disease of the hair follicle. Because FK506 has been described as suppressing T cell mediated autoimmune diseases, we addressed the question whether topical treatment of C3H/HeJ mice with FK506 has a beneficial effect on alopecia areata (AA). For this purpose six C3H/HeJ mice with AA were treated topically with 0.1% FK506 ointment, four mice received the vehicle only. Four of six FK506-treated mice showed complete hair regrowth, whereas 1/4 vehicle-treated mice regrew hair. Mice treated successfully with FK506 had reduced perifollicular infiltrates of CD4+ and CD8+ cells and a decreased expression of MHC class I and II and ICAM-1 on hair follicle epithelium, compared to control mice. We conclude that topical treatment with FK506 is able to induce hair regrowth in AA of C3H/HeJ mice, most likely by suppressing the T cell mediated immune response.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11525945&dopt=Abstract
philips.com
BACKGROUND/AIMS: The efficacy of single or multiple hair removal treatments reveals a number of properties of the hair follicle, such as the phase in the growing cycle and the hair growth speed. The aim of the present study was to provide a method to evaluate the results of hair removal treatments, in particular plucking, in order to obtain insight into some properties of the follicle and to propose a strategy for optimal treatment. Our hypothesis is that plucking of anagen hairs may result in either reset of the follicle to telogen, in mild damage to the follicle, resulting in a temporary reduction of the mitotic activity, or in an unaffected follicle, so that the hair continues to grow. METHODS: The regrowth of hairs after plucking was measured as a function of time for a number of subjects. Individual leg hairs within the areas observed were followed over time. Besides this, the growth speed of leg hairs was measured, and the extracted anagen hair length was determined to obtain an estimate of the anagen follicle depth on the leg. Monte Carlo simulations of the hair plucking and regrowth process were performed after the experiments. Some parameters derived from the experiments were used as inputs; others were fitted to achieve a good correlation between the result of the simulations and the experiments. Finally, the Monte Carlo routine was used to investigate the influence of the time interval between multiple plucking treatments. RESULTS: The regrowth of hairs after plucking, the growth speed and the extracted anagen hair length were measured. Both experiments and Monte Carlo simulations indicated that the result of plucking of an anagen hair is not limited to reset of the follicle to telogen or continued hair growth, but that a temporary reduction of the mitotic activity is very likely to occur. Finally, a linear relationship between the interval between epilation treatments and the average number of hairs on the skin was found using the Monte Carlo simulation. CONCLUSIONS: The combination of experiments and Monte Carlo simulations is a very successful strategy for studying hair removal and hair (re)growth in detail.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11554705&dopt=Abstract
Buy Lipitor Online
Herbs and Pharmaceuticals Online ||
Hair Million herbal formula for hair loss and hair growth ||
Hair growth research references ||
E-Mail Us